RI2A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Rigel Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 7.345 EUR

Market Cap: €363.4m

R	Rigel Pharmaceuticals Inc SWB:RI2A	US
	Aehr Test Systems NASDAQ:AEHR	US
	BioNTech SE LSE:0A3M	DE
J	Julius Baer Gruppe AG F:JGE	CH
	DocuSign Inc BMV:DOCU	US
	Goldstar Minerals Inc F:2OG0	CA
A	Atoss Software AG XHAM:AOF	DE
L	Lithium Ionic Corp OTC:LTHCF	CA
C	China Southern Airlines Co Ltd XMUN:ZNHH	CN
C	Crescent Point Energy Corp XBER:016	CA
T	Taiheiyo Cement Corp XBER:TIE	JP

Profitability Summary

Rigel Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

93%

Declining Gross Margin

98% > 93%

Exceptional Operating Margin

42%

Sustainable 3Y Average Operating Margin

11%

Operating Margin is Increasing

-27% > 42%

Exceptional Net Margin

122%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

-30% > 122%

Exceptional Free Cash Flow Margin

26%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-38% > 26%

Exceptional ROE

174%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

41%

ROIC is Increasing

-82% > 166%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.